Determinants of bone microarchitecture and mechanical properties in obese men
- PMID: 22933540
- PMCID: PMC3485587
- DOI: 10.1210/jc.2012-2246
Determinants of bone microarchitecture and mechanical properties in obese men
Abstract
Context: Recent studies have suggested that obesity in men is associated with increased fracture risk. Obesity in men is also associated with dysregulation of the GH/IGF-I and gonadal steroid axes, important regulators of bone homeostasis.
Objective: The aim of the study was to investigate body composition and endocrine determinants of bone microarchitecture and mechanical properties in obese men.
Design and setting: We conducted a cross-sectional study at a clinical research center.
Participants: Thirty-five obese men (mean age, 33.8 ± 6.4 yr; mean body mass index, 36.5 ± 5.8 kg/m(2)) participated in the study.
Outcome measures: Distal radius microarchitecture and mechanical properties were measured by three-dimensional high-resolution peripheral quantitative computed tomography and microfinite element analysis; body composition by computed tomography; bone marrow fat by proton magnetic resonance spectroscopy; total and free estradiol and testosterone; IGF-I; peak glucagon-stimulated GH; 25-hydroxyvitamin D.
Results: Men with high visceral adipose tissue (VAT) had impaired mechanical properties compared to men with low VAT (P < 0.05), despite comparable body mass index. VAT was inversely associated and thigh muscle was positively associated with mechanical properties (P < 0.05). Bone marrow fat was inversely associated with cortical parameters (P ≤ 0.02). Free estradiol was positively associated with total density (P = 0.05). Free testosterone was positively associated with trabecular thickness and inversely with trabecular number (P ≤ 0.05). Peak stimulated GH was positively associated with trabecular thickness, as was IGF-I with cortical area (P ≤ 0.04).
Conclusion: VAT and bone marrow fat are negative predictors and muscle mass is a positive predictor of microarchitecture and mechanical properties in obese men. Testosterone, estradiol, and GH are positive determinants of trabecular microarchitecture, and IGF-I is a positive determinant of cortical microarchitecture. This supports the notion that VAT is detrimental to bone and that decreased GH and testosterone, characteristic of male obesity, may exert deleterious effects on microarchitecture, whereas higher estradiol may be protective.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3485587/bin/zeg0111292950001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3485587/bin/zeg0111292950002.gif)
Similar articles
-
Determinants of bone mineral density in obese premenopausal women.Bone. 2011 Apr 1;48(4):748-54. doi: 10.1016/j.bone.2010.12.011. Epub 2010 Dec 30. Bone. 2011. PMID: 21195217 Free PMC article.
-
Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women.Obesity (Silver Spring). 2011 Jan;19(1):49-53. doi: 10.1038/oby.2010.106. Epub 2010 May 13. Obesity (Silver Spring). 2011. PMID: 20467419 Free PMC article.
-
Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men: the GOOD study.J Bone Miner Res. 2005 Aug;20(8):1334-41. doi: 10.1359/JBMR.050404. Epub 2005 Apr 11. J Bone Miner Res. 2005. PMID: 16007330
-
Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep.Sleep. 1996 Dec;19(10 Suppl):S221-4. doi: 10.1093/sleep/19.suppl_10.s221. Sleep. 1996. PMID: 9085516 Review.
-
Role of sex steroids hormones in the regulation of bone metabolism in men: Evidence from clinical studies.Best Pract Res Clin Endocrinol Metab. 2022 Mar;36(2):101624. doi: 10.1016/j.beem.2022.101624. Epub 2022 Feb 4. Best Pract Res Clin Endocrinol Metab. 2022. PMID: 35165044 Review.
Cited by
-
Links among Obesity, Type 2 Diabetes Mellitus, and Osteoporosis: Bone as a Target.Int J Mol Sci. 2024 Apr 28;25(9):4827. doi: 10.3390/ijms25094827. Int J Mol Sci. 2024. PMID: 38732046 Free PMC article. Review.
-
Bone Marrow Adipose Tissue.Cells. 2024 Apr 23;13(9):724. doi: 10.3390/cells13090724. Cells. 2024. PMID: 38727260 Free PMC article. Review.
-
Fat as a Friend or Foe of the Bone.Curr Osteoporos Rep. 2024 Apr;22(2):245-256. doi: 10.1007/s11914-024-00864-4. Epub 2024 Feb 28. Curr Osteoporos Rep. 2024. PMID: 38416274 Review.
-
Insufficient Bone Mineralization to Sustain Mechanical Load of Weight in Obese Boys: A Cross-Sectional Study.J Clin Endocrinol Metab. 2024 May 17;109(6):1443-1453. doi: 10.1210/clinem/dgad760. J Clin Endocrinol Metab. 2024. PMID: 38163968 Free PMC article.
-
Effect of Nutritional Deprivation after Sleeve Gastrectomy on Bone Mass, Periostin, Sclerostin and Semaphorin 4D: A Two-Year Longitudinal Study.Nutrients. 2023 Oct 10;15(20):4310. doi: 10.3390/nu15204310. Nutrients. 2023. PMID: 37892386 Free PMC article.
References
-
- Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. 2011. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378:815–825 - PubMed
-
- Wyatt HR. 2003. The prevalence of obesity. Prim Care 30:267–279 - PubMed
-
- Cole ZA, Dennison EM, Cooper C. 2008. Osteoporosis epidemiology update. Curr Rheumatol Rep 10:92–96 - PubMed
-
- Dawson-Hughes B, Looker AC, Tosteson AN, Johansson H, Kanis JA, Melton LJ., 3rd 2012. The potential impact of the National Osteoporosis Foundation guidance on treatment eligibility in the USA: an update in NHANES 2005–2008. Osteoporos Int 23:811–820 - PubMed
-
- Albala C, Yáñez M, Devoto E, Sostin C, Zeballos L, Santos JL. 1996. Obesity as a protective factor for postmenopausal osteoporosis. Int J Obes Relat Metab Disord 20:1027–1032 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical